reaction_smiles,sources,reactants,products,solvents,catalyst,stages
"['C(OC([N:8]1[CH2:13][CH2:12][CH:11]([CH2:14][O:15][C:16]2[CH:17]=[C:18]([O:23][S:24]([C:27]3[CH:32]=[CH:31][CH:30]=[CH:29][C:28]=3[Cl:33])(=[O:26])=[O:25])[CH:19]=[C:20]([CH3:22])[CH:21]=2)[CH2:10][CH2:9]1)=O)(C)(C)C.Cl', 'O1CCOCC1', '[NH:8]1[CH2:13][CH2:12][CH:11]([CH2:14][O:15][C:16]2[CH:17]=[C:18]([O:23][S:24]([C:27]3[CH:32]=[CH:31][CH:30]=[CH:29][C:28]=3[Cl:33])(=[O:25])=[O:26])[CH:19]=[C:20]([CH3:22])[CH:21]=2)[CH2:10][CH2:9]1']","['US20010025041A1', 'e) 2-Chlorobenzenesulfonic acid 3-[(piperidin4-yl)methoxy]-5-methylphenyl ester', '0177', '2-Chlorobenzenesulfonic acid 3-[[N-(tert-butoxycarbonyl)piperidin-4-yl]methoxy]-5-methylphenyl ester (745 mg, 1.5 mmol), as prepared in the preceding step, was treated with 4 N HCl in 1,4-dioxane (20 niL) at room temperature for 2 h. The solvent was removed in vacuo and the residue was purified by flash column chromatography (10% methanol in methylene chloride saturated with NH3) to give the title compound as a colorless syrup (570 mg, 95%). 1H-NMR (300 MHz, CDCl3) δ1.45 (m, 1 H), 1.94 (m, 3 H), 2.23 (s, 3 H), 2.45 (m, 1 H), 2.71 (dt, 2 H, J =1.2, 12.3 Hz), 3.51 (m, 2H), 3.76 (m, 2 H), 6.46 (t, 1 H, J =2.1 Hz), 6.53 (s, 1 H), 6.58 (s, 1 H), 7.40 (t, 1 H, J =6.5 Hz), 7.62 (m, 2 H), and 7.97 (dd,1 H, J =1.4, 7.9 Hz). Mass spectrum (MALDI-TOF, sinapinic acid matrix) calcd. for C19H22NO4SC1: 396.1 (M+H), Found: 396.4.']","[{'chemical_names': ['2-Chlorobenzenesulfonic acid 3-[[N-(tert-butoxycarbonyl)piperidin-4-yl]methoxy]-5-methylphenyl ester'], 'identifiers': ['smiles:Cc1cc(OCC2CCN(C(=O)OC(C)(C)C)CC2)cc(OS(=O)(=O)c2ccccc2Cl)c1', 'inchi:InChI=1S/C24H30ClNO6S/c1-17-13-19(15-20(14-17)32-33(28,29)22-8-6-5-7-21(22)25)30-16-18-9-11-26(12-10-18)23(27)31-24(2,3)4/h5-8,13-15,18H,9-12,16H2,1-4H3'], 'amounts': ['1.5 mmol', '745 mg'], 'appearances': []}, {'chemical_names': ['HCl'], 'identifiers': ['smiles:Cl', 'inchi:InChI=1S/ClH/h1H'], 'amounts': ['4 N'], 'appearances': []}]","[{'chemical_names': ['title compound', '2-Chlorobenzenesulfonic acid 3-[(piperidin4-yl)methoxy]-5-methylphenyl ester'], 'identifiers': ['smiles:Cc1cc(OCC2CCNCC2)cc(OS(=O)(=O)c2ccccc2Cl)c1', 'inchi:InChI=1S/C19H22ClNO4S/c1-14-10-16(24-13-15-6-8-21-9-7-15)12-17(11-14)25-26(22,23)19-5-3-2-4-18(19)20/h2-5,10-12,15,21H,6-9,13H2,1H3'], 'amounts': ['570 mg', '95%', '96.0'], 'appearances': ['colorless']}]","[{'chemical_names': ['1,4-dioxane'], 'identifiers': ['smiles:C1COCCO1', 'inchi:InChI=1S/C4H8O2/c1-2-6-4-3-5-1/h1-4H2'], 'amounts': [], 'appearances': []}]",[],"['step 1:2-Chlorobenzenesulfonic acid 3-[[N-(tert-butoxycarbonyl)piperidin-4-yl]methoxy]-5-methylphenyl ester (745 mg, 1.5 mmol), as prepared in the preceding step', 'step 2:was treated with 4 N HCl in 1,4-dioxane (20 niL) at room temperature for 2 h', 'step 2 properties:Time:7200', 'step 2 properties:Temperature:room temperature', 'step 3:The solvent was removed in vacuo', 'step 4:the residue was purified by flash column chromatography (10% methanol in methylene chloride saturated with NH3)', 'step 5:to give the title compound as a colorless syrup (570 mg, 95%)']"
"['[NH:1]1[CH2:6][CH2:5][CH2:4][CH:3]([CH2:7][OH:8])[CH2:2]1.C(N(CC)CC)C.[C:16](O[C:16]([O:18][C:19]([CH3:22])([CH3:21])[CH3:20])=[O:17])([O:18][C:19]([CH3:22])([CH3:21])[CH3:20])=[O:17]', 'O1CCOCC1', '[C:19]([O:18][C:16]([N:1]1[CH2:6][CH2:5][CH2:4][CH:3]([CH2:7][OH:8])[CH2:2]1)=[O:17])([CH3:22])([CH3:21])[CH3:20]']","['US20010025041A1', 'b) N-(tert-Butoxycarbonyl)-3-piperidinemethanol', '0260', 'To a solution of 3-piperidinemethanol (4.60 g, 40 mmol) and triethylamine (6 mL) in 1,4-dioxane (100 mL) was added slowly di-tert-butyl dicarbonate (8.72 g, 40 mmol). After stirring at room temperature for 2 h, the solvent was removed in vacuo and the residue purified by flash column chromatography (2:1 hexane/ethyl acetate) to give the title compound as white solid (7.81 g, 91%). 1H-NMR (300 MHz, CDCl3) δ1.25-1.39 (m, 2 H), 1.46 (s, 9 H), 1.60-1.81 (m, 3 H), 1.94 (br s,1 H), 2.98-3.08 (m, 2 H), 3.51 (d, 2 H), and 3.66-3.77 (m, 2 H).']","[{'chemical_names': ['3-piperidinemethanol'], 'identifiers': ['smiles:OCC1CCCNC1', 'inchi:InChI=1S/C6H13NO/c8-5-6-2-1-3-7-4-6/h6-8H,1-5H2'], 'amounts': ['40 mmol', '4.60 g'], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': ['6 mL'], 'appearances': []}, {'chemical_names': ['di-tert-butyl dicarbonate'], 'identifiers': ['smiles:CC(C)(C)OC(=O)OC(=O)OC(C)(C)C', 'inchi:InChI=1S/C10H18O5/c1-9(2,3)14-7(11)13-8(12)15-10(4,5)6/h1-6H3'], 'amounts': ['40 mmol', '8.72 g'], 'appearances': []}]","[{'chemical_names': ['title compound', 'N-(tert-Butoxycarbonyl)-3-piperidinemethanol'], 'identifiers': ['smiles:CC(C)(C)OC(=O)N1CCCC(CO)C1', 'inchi:InChI=1S/C11H21NO3/c1-11(2,3)15-10(14)12-6-4-5-9(7-12)8-13/h9,13H,4-8H2,1-3H3'], 'amounts': ['7.81 g', '91%', '90.7'], 'appearances': ['white']}]","[{'chemical_names': ['1,4-dioxane'], 'identifiers': ['smiles:C1COCCO1', 'inchi:InChI=1S/C4H8O2/c1-2-6-4-3-5-1/h1-4H2'], 'amounts': ['100 mL'], 'appearances': []}]",[],"['step 1:To a solution of 3-piperidinemethanol (4.60 g, 40 mmol) and triethylamine (6 mL) in 1,4-dioxane (100 mL) was added slowly di-tert-butyl dicarbonate (8.72 g, 40 mmol)', 'step 2:After stirring at room temperature for 2 h', 'step 2 properties:Time:7200', 'step 2 properties:Temperature:room temperature', 'step 3:the solvent was removed in vacuo', 'step 4:the residue purified by flash column chromatography (2:1 hexane/ethyl acetate)', 'step 5:to give the title compound as white solid (7.81 g, 91%)']"
"['C(OC([N:8]1[CH2:13][CH2:12][CH:11]([CH2:14][O:15][C:16]2[C:25]3[C:20](=[CH:21][CH:22]=[CH:23][CH:24]=3)[CH:19]=[C:18]([O:26][S:27]([C:30]3[CH:35]=[CH:34][CH:33]=[CH:32][C:31]=3[Cl:36])(=[O:29])=[O:28])[CH:17]=2)[CH2:10][CH2:9]1)=O)(C)(C)C.Cl', 'C(Cl)Cl.O1CCOCC1', '[ClH:36].[NH:8]1[CH2:13][CH2:12][CH:11]([CH2:14][O:15][C:16]2[C:25]3[C:20](=[CH:21][CH:22]=[CH:23][CH:24]=3)[CH:19]=[C:18]([O:26][S:27]([C:30]3[CH:35]=[CH:34][CH:33]=[CH:32][C:31]=3[Cl:36])(=[O:28])=[O:29])[CH:17]=2)[CH2:10][CH2:9]1 |f:4.5|']","['US20010025041A1', 'c) 2-Chlorobenzenesulfonic acid 1-[(piperidin4-yl)methoxy]naphthalen-3-yl ester hydrochloride', '0273', 'To a solution of 319 mg (0.596 mmol) of 2-chlorobenzenesulfonic acid 1-[[1-N-(tert-butoxycarbonyl)piperidin-4-yl]methoxy]naphthalen-3-yl ester, as prepared in the preceding step, in 2 mL of methylene chloride was added 1.5 mL (6 mmol) of 4 N HCl in dioxane. The reaction mixture was stirred for 1 h and triturated with diethyl ether to afford 281 mg of the title compound as a colorless powder. 1H-NMR (300 MHz, DMSO-d6) δ8.94 (bd, 1 H, J=9 Hz), 8.68 (bd, 1 H, J=10 Hz), 8.6 (d, 1 H, J=8 Hz), 7.8-7.98 (m, 4 Hz), 7.50-7.6 (m, 3 H), 7.18 (d, 1 H, J=2 Hz), 6.69 (d, 1 H, J=2 H), 3.94 (d, 2 H, J=7 Hz), 2.93 (q, 2 H), 2.16 (bm, 1 H), 1.96 (d, 2 H), and 1.57-1.71 (m, 2 H). Mass spectrum (MALDI-TOF; gentisic acid matrix) calcd. for C22H22ClNO4S: 432.1 (M+H). Found: 431.5.']","[{'chemical_names': ['2-chlorobenzenesulfonic acid 1-[[1-N-(tert-butoxycarbonyl)piperidin-4-yl]methoxy]naphthalen-3-yl ester'], 'identifiers': ['smiles:CC(C)(C)OC(=O)N1CCC(COc2cc(OS(=O)(=O)c3ccccc3Cl)cc3ccccc23)CC1', 'inchi:InChI=1S/C27H30ClNO6S/c1-27(2,3)34-26(30)29-14-12-19(13-15-29)18-33-24-17-21(16-20-8-4-5-9-22(20)24)35-36(31,32)25-11-7-6-10-23(25)28/h4-11,16-17,19H,12-15,18H2,1-3H3'], 'amounts': ['0.596 mmol', '319 mg'], 'appearances': []}, {'chemical_names': ['HCl'], 'identifiers': ['smiles:Cl', 'inchi:InChI=1S/ClH/h1H'], 'amounts': ['6 mmol', '4 N', '1.5 mL'], 'appearances': []}]","[{'chemical_names': ['title compound', '2-Chlorobenzenesulfonic acid 1-[(piperidin4-yl)methoxy]naphthalen-3-yl ester hydrochloride'], 'identifiers': ['smiles:Cl.O=S(=O)(Oc1cc(OCC2CCNCC2)c2ccccc2c1)c1ccccc1Cl', 'inchi:InChI=1S/C22H22ClNO4S.ClH/c23-20-7-3-4-8-22(20)29(25,26)28-18-13-17-5-1-2-6-19(17)21(14-18)27-15-16-9-11-24-12-10-16;/h1-8,13-14,16,24H,9-12,15H2;1H'], 'amounts': ['281 mg', '201.3'], 'appearances': ['colorless']}]","[{'chemical_names': ['methylene chloride'], 'identifiers': ['smiles:ClCCl', 'inchi:InChI=1S/CH2Cl2/c2-1-3/h1H2'], 'amounts': ['2 mL'], 'appearances': []}, {'chemical_names': ['dioxane'], 'identifiers': ['smiles:C1COCCO1', 'inchi:InChI=1S/C4H8O2/c1-2-6-4-3-5-1/h1-4H2'], 'amounts': [], 'appearances': []}]",[],"['step 1:To a solution of 319 mg (0.596 mmol) of 2-chlorobenzenesulfonic acid 1-[[1-N-(tert-butoxycarbonyl)piperidin-4-yl]methoxy]naphthalen-3-yl ester, as prepared in the preceding step, in 2 mL of methylene chloride', 'step 2:was added 1.5 mL (6 mmol) of 4 N HCl in dioxane', 'step 3:The reaction mixture was stirred for 1 h', 'step 3 properties:Time:3600', 'step 4:triturated with diethyl ether', 'step 5:to afford 281 mg of the title compound as a colorless powder']"
"['[Cl:1][C:2]1[CH:30]=[CH:29][CH:28]=[CH:27][C:3]=1[O:4][CH2:5][C:6]1[CH:11]=[CH:10][CH:9]=[C:8]([O:12][CH2:13][CH:14]2[CH2:19][CH2:18][N:17](C(OC(C)(C)C)=O)[CH2:16][CH2:15]2)[CH:7]=1.Cl', 'C(Cl)Cl.O1CCOCC1', '[ClH:1].[Cl:1][C:2]1[CH:30]=[CH:29][CH:28]=[CH:27][C:3]=1[O:4][CH2:5][C:6]1[CH:11]=[CH:10][CH:9]=[C:8]([O:12][CH2:13][CH:14]2[CH2:15][CH2:16][NH:17][CH2:18][CH2:19]2)[CH:7]=1 |f:4.5|']","['US20010025041A1', 'c) 1-[(2-Chlorophenoxy)methyl]-3-[(piperidin-4-yl)methoxy]benzene hydrochloride', '0282', 'A solution of 215 mg of 1-[(2-chlorophenoxy)methyl]-3-[[N-(tert-butoxycarbonyl)piperidin-4-yl]methoxy]benzene, as prepared in the preceding step, in methylene chloride (2 mL) was treated with 1.5 mL of 4 N HCl in dioxane. The reaction mixture was stirred at ambient temperature for 1 h, and then concentrated to provide 183 mg of the title compound as a colorless powder after repeated concentrations from diethyl ether/hexane/methanol. 1H-NMR (300 MHz, DMSO-d6) δ8.51 (br s, 2 H), 7.45 (dd, 1 H, J=1.3, 7.9 Hz), 7.27-7.35 (m, 2 H), 7.21 (d, 1 H), 6.90-7.05 (m, 4 H), 5.18 (s, 2 H), 3.87 (d, 2 H), 2.90 (t, 2 H, J=10Hz), 2.05 (m, 1 H), 1.91 (d, 2 H, J=13.8 Hz), and 1.5-1.54 (m, 2 H). Mass spectrum (MALDI-TOF; α-cyano-4-hydroxycinnamic acid matrix) calcd. for C19H22ClNO2: 332.1 (M+H). Found: 332.0.']","[{'chemical_names': ['1-[(2-chlorophenoxy)methyl]-3-[[N-(tert-butoxycarbonyl)piperidin-4-yl]methoxy]benzene'], 'identifiers': ['smiles:CC(C)(C)OC(=O)N1CCC(COc2cccc(COc3ccccc3Cl)c2)CC1', 'inchi:InChI=1S/C24H30ClNO4/c1-24(2,3)30-23(27)26-13-11-18(12-14-26)16-28-20-8-6-7-19(15-20)17-29-22-10-5-4-9-21(22)25/h4-10,15,18H,11-14,16-17H2,1-3H3'], 'amounts': ['215 mg'], 'appearances': []}, {'chemical_names': ['HCl'], 'identifiers': ['smiles:Cl', 'inchi:InChI=1S/ClH/h1H'], 'amounts': ['4 N', '1.5 mL'], 'appearances': []}]","[{'chemical_names': ['title compound', '1-[(2-Chlorophenoxy)methyl]-3-[(piperidin-4-yl)methoxy]benzene hydrochloride'], 'identifiers': ['smiles:Cl.Clc1ccccc1OCc1cccc(OCC2CCNCC2)c1', 'inchi:InChI=1S/C19H22ClNO2.ClH/c20-18-6-1-2-7-19(18)23-14-16-4-3-5-17(12-16)22-13-15-8-10-21-11-9-15;/h1-7,12,15,21H,8-11,13-14H2;1H'], 'amounts': ['183 mg', '199.7'], 'appearances': ['colorless']}]","[{'chemical_names': ['methylene chloride'], 'identifiers': ['smiles:ClCCl', 'inchi:InChI=1S/CH2Cl2/c2-1-3/h1H2'], 'amounts': ['2 mL'], 'appearances': []}, {'chemical_names': ['dioxane'], 'identifiers': ['smiles:C1COCCO1', 'inchi:InChI=1S/C4H8O2/c1-2-6-4-3-5-1/h1-4H2'], 'amounts': [], 'appearances': []}]",[],"['step 1:A solution of 215 mg of 1-[(2-chlorophenoxy)methyl]-3-[[N-(tert-butoxycarbonyl)piperidin-4-yl]methoxy]benzene, as prepared in the preceding step, in methylene chloride (2 mL)', 'step 2:was treated with 1.5 mL of 4 N HCl in dioxane', 'step 3:The reaction mixture was stirred at ambient temperature for 1 h', 'step 3 properties:Time:3600', 'step 3 properties:Temperature:room temperature', 'step 4:concentrated', 'step 5:to provide 183 mg of the title compound as a colorless powder']"
"['[NH2:1][C:2]1[CH:11]=[CH:10][CH:9]=[C:8]2[C:3]=1[CH2:4][CH2:5][NH:6][CH2:7]2.[OH-].[Na+].[C:14]([O:18][C:19](O[C:19]([O:18][C:14]([CH3:17])([CH3:16])[CH3:15])=[O:20])=[O:20])([CH3:17])([CH3:16])[CH3:15].O', 'O1CCOCC1', '[NH2:1][C:2]1[CH:11]=[CH:10][CH:9]=[C:8]2[C:3]=1[CH2:4][CH2:5][N:6]([C:19]([O:18][C:14]([CH3:17])([CH3:16])[CH3:15])=[O:20])[CH2:7]2 |f:1.2|']","['US20010025045A1', '5-Amino-2-(tert-butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline', '0161', 'An ice cold solution of 5-amino-1,2,3,4-tetrahydroisoquinoline (6.45g, 44mmol) in 1,4-dioxane (250ml) was treated with 3M sodium hydroxide (14.7ml, 44mmol), and di-tert-butyl-dicarbonate (9.57ml, 44mmol) and the solution was stirred at room temperature overnight. The reaction mixture was then poured into water (400ml) and extracted with ether. The organic phases were dried over sodium sulfate and concentrated in vacuo to afford a brown oil which solidified on standing and was recrystallised from ethanol/petrol to afford the title compound as an off white crystalline solid (5.1g).']","[{'chemical_names': ['ice'], 'identifiers': [], 'amounts': [], 'appearances': []}, {'chemical_names': ['5-amino-1,2,3,4-tetrahydroisoquinoline'], 'identifiers': ['smiles:Nc1cccc2c1CCNC2', 'inchi:InChI=1S/C9H12N2/c10-9-3-1-2-7-6-11-5-4-8(7)9/h1-3,11H,4-6,10H2'], 'amounts': ['44mmol', '6.45g'], 'appearances': []}, {'chemical_names': ['sodium hydroxide'], 'identifiers': ['smiles:[Na+].[OH-]', 'inchi:InChI=1S/Na.H2O/h;1H2/q+1;/p-1'], 'amounts': ['44mmol', '3M', '14.7ml'], 'appearances': []}, {'chemical_names': ['di-tert-butyl-dicarbonate'], 'identifiers': ['smiles:CC(C)(C)OC(=O)OC(=O)OC(C)(C)C', 'inchi:InChI=1S/C10H18O5/c1-9(2,3)14-7(11)13-8(12)15-10(4,5)6/h1-6H3'], 'amounts': ['44mmol', '9.57ml'], 'appearances': []}, {'chemical_names': ['water'], 'identifiers': ['smiles:O', 'inchi:InChI=1S/H2O/h1H2'], 'amounts': ['400ml'], 'appearances': []}]","[{'chemical_names': ['title compound', '5-Amino-2-(tert-butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline'], 'identifiers': ['smiles:CC(C)(C)OC(=O)N1CCc2c(N)cccc2C1', 'inchi:InChI=1S/C14H20N2O2/c1-14(2,3)18-13(17)16-8-7-11-10(9-16)5-4-6-12(11)15/h4-6H,7-9,15H2,1-3H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['solid'], 'identifiers': [], 'amounts': ['5.1g'], 'appearances': []}]","[{'chemical_names': ['1,4-dioxane'], 'identifiers': ['smiles:C1COCCO1', 'inchi:InChI=1S/C4H8O2/c1-2-6-4-3-5-1/h1-4H2'], 'amounts': ['250ml'], 'appearances': []}]",[],"['step 1:An ice cold solution of 5-amino-1,2,3,4-tetrahydroisoquinoline (6.45g, 44mmol) in 1,4-dioxane (250ml) was treated with 3M sodium hydroxide (14.7ml, 44mmol), and di-tert-butyl-dicarbonate (9.57ml, 44mmol)', 'step 2:the solution was stirred at room temperature overnight', 'step 2 properties:Time:overnight', 'step 2 properties:Temperature:room temperature', 'step 3:The reaction mixture was then poured into water (400ml)', 'step 4:extracted with ether', 'step 5:The organic phases were dried over sodium sulfate', 'step 6:concentrated in vacuo', 'step 7:to afford a brown oil which', 'step 8:was recrystallised from ethanol/petrol', 'step 9:to afford the title compound as an off white crystalline solid (5.1g)']"
"['[NH2:1][C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[CH2:8][NH:7][CH2:6][CH2:5]2.[OH-].[Na+].[C:14](O[C:14]([O:16][C:17]([CH3:20])([CH3:19])[CH3:18])=[O:15])([O:16][C:17]([CH3:20])([CH3:19])[CH3:18])=[O:15]', 'O1CCOCC1', '[NH2:1][C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[CH2:8][N:7]([C:14]([O:16][C:17]([CH3:20])([CH3:19])[CH3:18])=[O:15])[CH2:6][CH2:5]2 |f:1.2|']","['US20010025045A1', '6-Amino-2-(t-butyloxycarbonyl)-1,2,3,4-tetrahydroisoquinoline', '0419', 'A solution of 6-amino-1,2,3,4-tetrahydroisoquinoline (0.74g; 5 mmol) in 1,4-dioxan (50ml) containing 5M-NaOH (1ml) was stirred at 5° C. and treated with di t butyl dicarbonate (1.09g; 5 mmol). After 20 min at room temperature the product was extracted with ethyl acetate and the material in the organic layer gave a brown gum which was chromatographed on Kieselgel 60 in 5% methanol:dichloromethane. The title compound was obtained as a pale gum (0.55g).']","[{'chemical_names': ['6-amino-1,2,3,4-tetrahydroisoquinoline'], 'identifiers': ['smiles:Nc1ccc2c(c1)CCNC2', 'inchi:InChI=1S/C9H12N2/c10-9-2-1-8-6-11-4-3-7(8)5-9/h1-2,5,11H,3-4,6,10H2'], 'amounts': ['5 mmol', '0.74g'], 'appearances': []}, {'chemical_names': ['NaOH'], 'identifiers': ['smiles:[Na+].[OH-]', 'inchi:InChI=1S/Na.H2O/h;1H2/q+1;/p-1'], 'amounts': ['1ml'], 'appearances': []}, {'chemical_names': ['di t butyl dicarbonate'], 'identifiers': ['smiles:CC(C)(C)OC(=O)OC(=O)OC(C)(C)C', 'inchi:InChI=1S/C10H18O5/c1-9(2,3)14-7(11)13-8(12)15-10(4,5)6/h1-6H3'], 'amounts': ['5 mmol', '1.09g'], 'appearances': []}]","[{'chemical_names': ['title compound', '6-Amino-2-(t-butyloxycarbonyl)-1,2,3,4-tetrahydroisoquinoline'], 'identifiers': ['smiles:CC(C)(C)OC(=O)N1CCc2cc(N)ccc2C1', 'inchi:InChI=1S/C14H20N2O2/c1-14(2,3)18-13(17)16-7-6-10-8-12(15)5-4-11(10)9-16/h4-5,8H,6-7,9,15H2,1-3H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['gum'], 'identifiers': [], 'amounts': ['0.55g'], 'appearances': []}]","[{'chemical_names': ['1,4-dioxan'], 'identifiers': ['smiles:C1COCCO1', 'inchi:InChI=1S/C4H8O2/c1-2-6-4-3-5-1/h1-4H2'], 'amounts': ['50ml'], 'appearances': []}]",[],"['step 1:A solution of 6-amino-1,2,3,4-tetrahydroisoquinoline (0.74g; 5 mmol) in 1,4-dioxan (50ml) containing 5M-NaOH (1ml)', 'step 2:was stirred at 5° C.', 'step 2 properties:Temperature:5', 'step 3:treated with di t butyl dicarbonate (1.09g; 5 mmol)', 'step 4:After 20 min at room temperature the product was extracted with ethyl acetate', 'step 4 properties:Time:1200', 'step 4 properties:Temperature:room temperature', 'step 5:the material in the organic layer gave a brown gum which', 'step 6:was chromatographed on Kieselgel 60 in 5% methanol', 'step 7:The title compound was obtained as a pale gum (0.55g)']"
"['[C:1]([C:7]1[CH:8]=[CH:9][C:10]([O:15][CH3:16])=[C:11]([CH:14]=1)[CH2:12][OH:13])(=[O:6])[C:2]([CH3:5])([CH3:4])[CH3:3].[OH-].[K+].[O-:19][Mn](=O)(=O)=O.[K+]', 'O1CCOCC1', '[C:1]([C:7]1[CH:8]=[CH:9][C:10]([O:15][CH3:16])=[C:11]([CH:14]=1)[C:12]([OH:19])=[O:13])(=[O:6])[C:2]([CH3:5])([CH3:4])[CH3:3] |f:1.2,3.4|']","['US20010025045A1', '5-Pivaloyl-2-methoxy benzoic acid', '0448', '5-Pivaloyl-2-methoxy benzyl alcohol (1.19g, 5.35 mmol) was dissolved in dioxane (20ml). A solution of KOH (0.449g, 8.025 mmol in water (5ml)) was added followed by KMnO4 (1.69g, 10.7 mmol). The mixture was allowed to stir at room temperature over the weekend. The solution was filtered through Celite and extracted with ether. The aqueous phase was acidified with dil. HCl and extracted with ether (3×50ml). The organic layer was dried over magnesium sulphate and concentrated in vacuo to afford the title compound as a white solid (1.06g).']","[{'chemical_names': ['5-Pivaloyl-2-methoxy benzyl alcohol'], 'identifiers': ['smiles:COc1ccc(C(=O)C(C)(C)C)cc1CO', 'inchi:InChI=1S/C13H18O3/c1-13(2,3)12(15)9-5-6-11(16-4)10(7-9)8-14/h5-7,14H,8H2,1-4H3'], 'amounts': ['5.35 mmol', '1.19g'], 'appearances': []}, {'chemical_names': ['KOH'], 'identifiers': ['smiles:[K+].[OH-]', 'inchi:InChI=1S/K.H2O/h;1H2/q+1;/p-1'], 'amounts': ['8.025 mmol', '5ml', '0.449g'], 'appearances': []}, {'chemical_names': ['KMnO4'], 'identifiers': ['smiles:O=[Mn](=O)(=O)[O-].[K+]', 'inchi:InChI=1S/K.Mn.4O/q+1;;;;;-1'], 'amounts': ['10.7 mmol', '1.69g'], 'appearances': []}]","[{'chemical_names': ['title compound', '5-Pivaloyl-2-methoxy benzoic acid'], 'identifiers': ['smiles:COc1ccc(C(=O)C(C)(C)C)cc1C(=O)O', 'inchi:InChI=1S/C13H16O4/c1-13(2,3)11(14)8-5-6-10(17-4)9(7-8)12(15)16/h5-7H,1-4H3,(H,15,16)'], 'amounts': ['1.06g', '83.9'], 'appearances': ['white']}]","[{'chemical_names': ['dioxane'], 'identifiers': ['smiles:C1COCCO1', 'inchi:InChI=1S/C4H8O2/c1-2-6-4-3-5-1/h1-4H2'], 'amounts': ['20ml'], 'appearances': []}]",[],"['step 1:5-Pivaloyl-2-methoxy benzyl alcohol (1.19g, 5.35 mmol) was dissolved in dioxane (20ml)', 'step 2:A solution of KOH (0.449g, 8.025 mmol in water (5ml)) was added', 'step 3:to stir at room temperature over the weekend', 'step 3 properties:Temperature:room temperature', 'step 4:The solution was filtered through Celite', 'step 5:extracted with ether', 'step 6:extracted with ether (3×50ml)', 'step 7:The organic layer was dried over magnesium sulphate', 'step 8:concentrated in vacuo', 'step 9:to afford the title compound as a white solid (1.06g)']"
